Fundraising FoxDYDX Capital — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
AI Engine for Complex After-Market Service
Co-investorsArka Venture LabsMoment Ventures, LlcPrana Tech VenturesNivesha Ventures
Cime Therapeutics is developing a chemistry-first drug discovery platform that combines automation, AI/ML, and synthetic chemistry to make molecules faster and more cost-effectively.
AI & Machine LearningBiotechDeep TechDenver, US
James Brewster(Chief Executive Officer)inJames Thomas Brewster II(Executive Officer, Director)
BoardChris Erickson(Director)in
Co-investorsRange VCService Provider Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.